Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Clin Cancer Res. 2011 May 12;17(13):4309–4319. doi: 10.1158/1078-0432.CCR-10-1820

Table 1.

Demographic and staging data for multiple myeloma patients in this study.

Newly diagnosed n=46 Relapsed n=35
Age 62.0 ± 1.5 yrs 57.7 ± 1.5 yrs
Sex M = 27, F = 19 M = 20, F = 15
Heavy chain isotype IgG = 26
IgA = 10
IgM = 1
IgG + IgA = 1
Light chain only = 8
IgG = 18
IgA = 3
IgM = 1
IgD = 1
Light chain only = 7
Oligosecretory = 4
Light chain isotype Kappa = 31
Lambda = 15
Kappa = 23
Lambda = 11
Not done = 1
Cytogenetics Normal = 32
Del(20q) = 1
Inv(2) = 1
Inv(9) = 2
Y(-) = 2
Complex t(1;8); t(11;14); t(12;27) = 1
Not done = 7
Normal = 18
Complex = 7
Complex incl.
t(5;13)(q31;q14) = 1
Inv(9) =1
Not done = 8
FISH Normal = 15
Del (13q14) = 4
Complex incl. del(13q14) = 7
t(11;14) = 4
t(4;14) = 1
Trisomy/ tetrasomy 11 = 5
Trisomy 11/ trisomy 17 = 1
Complex = 1
Not done = 8
Normal = 19
t(11;14) =2
Del(13) = 2
Trisomy 11 = 1
Trisomy 11 + del(13q14) = 1
Complex = 1
Not done = 9
Serum β2-microglobulin 4.8 ± 0.6 mg/ dL 4.7 ± 0.7 mg/ dL
Serum albumin 3.6 ± 0.1 mg/ dL 3.5 ± 0.1 mg/ dL
Hemoglobin 10.4 ± 0.4 gm/ dL 10.2 ± 0.3 gm/ dL
Serum creatinine 1.5 ± 0.2 mg/ dL 2.2 ± 0.4 mg/ dL